Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Youths who survive self-poisoning continue to be at risk of suicide for years

  • We are family: Adult support reduces youths' risk of violence exposure

  • Parents sound off on mobile device use by children

  • Some children lose autism diagnosis but still struggle

  • Serving healthy foods with a smile may entice students to eat better

  • Mental disorders don't predict future violence, study suggests

  • High radiotherapy dose improves prospects for children with brain cancer

  • Resilience, not abstinence, may help teens battle online risk

  • Glimpses of how the brain transforms sound

  • Connecting places causes mental maps to merge

  •